Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.

The most dangerous animal in the world just got easier to study—and perhaps defeat one day. Researchers from Rockefeller ...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular innovation, today announced the official launch of ...

Winston Timp, the principal investigator of the Timp Lab and associate professor of Biomedical Engineering (BME) at the ...

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...

Innovative cancer therapies are transforming treatment landscapes, yet access challenges persist. Experts discuss strategies ...

A research team has uncovered how peanuts develop their remarkable underground pods by constructing the first single-cell ...

Research institutes are projected to capture 50% of total market revenue in 2025, reflecting their pivotal role in genomic innovation. These institutions rely heavily on high-throughput sequencing ...

Twist Bioscience is advancing synthetic DNA manufacturing with innovation but remains at the lower end of its 52-week range.

MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life ...

As we enter entrepreneurship month this November, we’re celebrating the professors and alumni who are fueling job creation ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.